This invention discloses an endogenous polypeptide, its preparation method, and its application. The
structural formula of the polypeptide is shown in Formula (I): R1-(AA1)m-AA2-AA3-(AA4)n-R2, Formula (I); wherein, m is independently 2 or 3; n is independently 1, 2, or 3; AA1 is independently K, R, or H; AA2 is independently I or W; AA3 is independently I or W; AA4 is independently K, R, or H; R1 is any one of -H, Y, LY, PLY, or LLY; R2 is any one of -OH, L, LL, E, EL, EW, W, EH, or EHL. While retaining its targeted
antioxidant and anti-inflammatory functions, the polypeptide has removed the domain with high affinity for
heparin, thereby avoiding
signal interference and potential
biosafety risks that may be caused by full-length PF4, and meeting the safety requirements for cosmetic ingredients.